SCHEMBL4346884

SCHEMBL4346884

CCO[Si](OCC)(OCC)c1ccc(-c2c([Si](OCC)(OCC)OCC)ccc(-c3ccccc3)c2-c2ccccc2)cc1

nearest known ligand 0.33

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.32
ALDH1A1 P00352 3/20 0.32
RAB9A P51151 3/20 0.32
KDM4E B2RXH2 2/20 0.32
HPGD P15428 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
LMNA P02545 1/20 0.32
GAA P10253 1/20 0.32
MAPT P10636 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
MAPK1 P28482 1/20 0.32
USP7 Q93009 2/20 0.32
DHFR P00374 1/20 0.31
HEXA P06865 1/20 0.31
HEXB P07686 1/20 0.31
CNR1 P21554 1/20 0.31
CNR2 P34972 1/20 0.31
GPR55 Q9Y2T6 1/20 0.31
TP53 P04637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2777619 0.79 SMN1; SMN2 (0.40) NPC1ALDH1A1RAB9AKDM4EHPGD
SCHEMBL14264690 0.79 SMN1; SMN2 (0.40) NPC1ALDH1A1RAB9AKDM4EHPGD
SCHEMBL5487167 0.79 ALDH1A1 (0.35) NPC1ALDH1A1RAB9AKDM4EHPGD
SCHEMBL27923911 0.77 MAPT (0.39) NPC1ALDH1A1RAB9AKDM4EHPGD
SCHEMBL4354037 0.76 SMN1; SMN2 (0.36) NPC1ALDH1A1RAB9AKDM4EHPGD
SCHEMBL27444686 0.75 NPC1 (0.38) NPC1ALDH1A1RAB9AKDM4EHPGD
SCHEMBL1639899 0.74 SOAT1 (0.33) NPC1ALDH1A1RAB9AKDM4EHPGD
Biphenyl SCHEMBL28100853 0.74 ALDH1A1 (0.39) NPC1ALDH1A1RAB9AKDM4EHPGD
SCHEMBL13978508 0.73 NPC1 (0.31) NPC1ALDH1A1RAB9AKDM4EHPGD
SCHEMBL4279699 0.73 ADRB2 (0.37) NPC1ALDH1A1RAB9AKDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090054649-A1 Bridged Organosilane and Production Method Thereof KABUSHIKI KAISHA TOYOTA CHUO KENKYUSHO (JP) 2009-02-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054649-A1 Bridged Organosilane and Production Method Thereof C5, CCNE1, QSOX1 NPC1 1178/4885ALDH1A1 866/4885RAB9A 1423/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.